BRENDA NUNLEY: Open Payments
NPI 1891923702 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 47 payments from 18 companies in 2025. Trend: 2023 $872 · 2024 $1,006 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $288 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| PFIZER INC. | 2 | $46 |
| Amgen Inc. | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Radius Health, Inc. | 1 | $24 |
Products named: VRAYLAR, REXULTI, CAPLYTA, NURTEC ODT, EVENITY, UBRELVY, TRINTELLIX, GEMTESA.
Industry payments across NE — which companies pay providers there.
